Rivaroxaban

Nonvalvular Atrial Fibrillation: 15 or 20 mg, once daily with food Treatment of DVT and/or PE: 15 mg orally twice daily with food for the first 21 days followed by 20 mg orally once daily with food for the remaining treatment Reduction in the Risk of Recurrence of DVT and/or PE in patients at continued risk for DVT and/or PE: 10 mg once daily with or without food…

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

XARELTO is contraindicated in patients with: active pathological bleeding severe hypersensitivity reaction to XARELTO (e.g., anaphylactic reactions) Active pathological bleeding Severe hypersensitivity reaction to XARELTO

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Risk of bleeding: XARELTO can cause serious and fatal bleeding Pregnancy-related hemorrhage: Use XARELTO with caution in pregnant women due to the potential for obstetric hemorrhage and/or emergent delivery Prosthetic heart valves: XARELTO use not recommended Increased Risk of Thrombosis in Patients with Triple Positive Antiphospholipid Syndrome: XARELTO use not recommended 5.1 Increased Risk of Thrombotic Events after Premature Discontinuation Premature discontinuation of any oral anticoagulant, including XARELTO, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following clinically significant adverse reactions are also discussed in other sections of the labeling: Increased Risk of Stroke After Discontinuation in Nonvalvular Atrial Fibrillation Bleeding Risk Spinal/Epidural Hematoma The most common adverse reaction (>5%) in adult patients was bleeding The most common adverse reactions (>10%) in pediatric patients were bleeding, cough, vomiting, and gastroenteritis To report…

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

143 products from 43 makers in the NepalDoc medicine catalog use this generic:

Showing 30 of 143 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Of tablets, granules and reconstituted suspension: Store at room temperature between 20 °C to 25 °C (68 °F to 77 °F); excursions permitted between 15 °C to 30 °C (59 °F to 86 °F). Do not freeze the granules or reconstituted suspension. Keep out of the reach of children.

Storage information from the U.S. FDA-approved label.